Drug Trial Radar · NCT07477704
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
438
Actual
Start
Jun 17, 2026
Primary completion
Dec 29, 2026
Study completion Feb 23, 2027
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- First posted
- Mar 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching an experimental drug called alirocumab, referred to as "study drug". In the United States, alirocumab is approved for the treatment of hypercholesterolemia (high blood cholesterol levels). The aim of the study is to see how safe and effective alirocumab is when given weekly to adult participants who have hypercholesterolemia. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug once a week * How much study drug is in the blood at different times
Conditions
- Hypercholesterolemia
Interventions
AlirocumabDrug
Administered per the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change in LDL-CTime frame: From Baseline through Week 12
Locations
34 sites in 1 country. Site status is shown where the registry gives one.
Pinnacle Research Group
Anniston, Alabama
Cullman Clinical Trials
Cullman, Alabama
Anaheim Clinical Trials
Anaheim, California
Cenexel CNS
Los Alamitos, California
Diablo Clinical Research - Flourish Research
Walnut Creek, California
Tampa Bay Medical Research
Clearwater, Florida
Southwest General Healthcare Center
Fort Myers, Florida
Precision Clinical Research
Sunrise, Florida
K2 Medical Research The Villages
The Villages, Florida
Center for Advanced Research and Education
Gainesville, Georgia
Balanced Life Health Care Solutions
Lawrenceville, Georgia
East-West Medical Research Institute
Honolulu, Hawaii
L-MARC Research Center
Louisville, Kentucky
Tandem Clinical Research
Marrero, Louisiana
Mercury Street Medical Group, PLLC
Butte, Montana
Velocity Clinical Research - Omaha
Omaha, Nebraska
Palm Research Center, Mountainview Medical Center
Las Vegas, Nevada
Velocity Clinical Research - Durham
Durham, North Carolina
Accellacare of Wilmington
Wilmington, North Carolina
Ohio Clinical Trials
Columbus, Ohio
AMR Norman
Norman, Oklahoma
Lynn Health Science Institute
Oklahoma City, Oklahoma
Velocity Clinical Research, Medford
Medford, Oregon
Altoona Center for Clinical Research
Duncansville, Pennsylvania
Tribe Clinical Research
Greenville, South Carolina
Coastal Carolina Research Center_North Charleston
North Charleston, South Carolina
Velocity Clinical Research Dallas
Dallas, Texas
Valley Institute of Research, Rockwood Medical Clinic
Fort Worth, Texas
Be Well Clinical Studies - Round Rock
Round Rock, Texas
Flourish Research, Legacy Oaks Tower
San Antonio, Texas
Endeavor Clinical Trials
San Antonio, Texas
Consano Clinical Research, LLC
Shavano Park, Texas
Charlottesville Medical Research
Charlottesville, Virginia
Rainier Clinical Research Center
Renton, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.